Researchers at Griffith University have discovered a tentative but plausible link between nose picking and an increased risk ...

Neoadjuvant immunotherapy could considerably improve long-term outcomes and quality of life for patients with desmoplastic melanoma, according to prospective study results.Nearly three-quarters of ...

The global microbiology culture market is expected to grow at a compound annual growth rate (CAGR) of approximately 6% during the forecast period. This growth is driven by several factors, including ...

Bristol Myers Squibb BMY-0.64%decrease; red down pointing triangle reported higher fourth-quarter revenue as growth in sales of its immuno-oncology treatments helped to offset a decline in revenue for ...

Lugano, 4 December 2025 – The ESMO Immuno-Oncology Congress 2025 will take place from 10–12 December in London, UK, bringing together specialists in cancer immunotherapy to present and discuss ...

Prospective Study of Annual Whole-Body Magnetic Resonance Imaging as Part of a Multimodality Screening Program for Individuals With Li-Fraumeni Syndrome We performed a retrospective cohort study of ...

Traumatic brain injury, together with adjacent brain conditions such as Alzheimer’s disease, is a global health crisis. In this presentation, Aleksandra Hemm, Product Manager from Thermo Fisher ...

Young lung cancer patients have a higher incidence of targetable biomarkers, necessitating comprehensive testing for ALK fusions and EGFR mutations. Repeat biomarker testing is essential when ...

Abstract: Serological tests play important roles in the fight against the Coronavirus Disease 2019 (COVID-19). The most commonly used methods, enzyme-linked immunosorbent assays (ELISA), provide ...

Promising new inroads into critical DNA testing has been forecast by experts who have applied machine learning to DNA profiling. From medical diagnostics to forensic tests and national security, PCR ...

AstraZeneca is extending its work with Immunai through a multiyear collaboration that aims to implement its artificial-intelligence-powered immune cell atlas in the design of the drugmaker’s clinical ...